Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02916888 · ClinicalTrials.gov registry record
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 26
- Enrollment target
NCT02916888: Completed study, sponsored by Yale University.
NCT02916888 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02916888 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the differences in the quality of life of patients and caregivers who are treated by general pediatricians versus pediatric dermatologists for eczema (atopic dermatitis or AD).
Primary Outcome
Measured using Infant's Dermatitis Quality of Life Index (IDQoL) or Children's Dermatology Life Quality Index(CDLQI) depending on age
Interventions
- OTHER Care provided by general pediatrician
- OTHER Care provided by pediatric dermatologist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-12 |
What the finished NCT02916888 record still lists
NCT02916888 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Care provided by general pediatrician is the first listed.
NCT02916888 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02916888 about?
NCT02916888 is a clinical study titled "A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists". The purpose of this study is to investigate the differences in the quality of life of patients and caregivers who are treated by general pediatricians versus pediatric dermatologists for eczema (atopic dermatitis or AD).
What is the current status of trial NCT02916888?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2016-09. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02916888?
The interventions under investigation include: Care provided by general pediatrician (OTHER), Care provided by pediatric dermatologist (OTHER).
Who is sponsoring clinical trial NCT02916888?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia